Purpose: To evaluate detailed changes in retinal layer thickness in spectraldomain optical coherence tomography (SD-OCT) images during a 1-year followup of patients treated for diabetic macula oedema (DME). Methods: Post hoc analysis of retinal layer thickness changes applying the automated layer segmentation of SD-OCT images in eyes with DME that were randomly assigned to receive pro re nata (PRN) treatment with either 0.5 mg ranibizumab or 8 mg triamcinolone. In each patient, seven retinal layers were segmented in 49 scans covering a 20°3 20°area of the macula at baseline and after 1 year of treatment. Changes in individual layer thickness were correlated with visual acuity (VA) and compared between treatment arms. Results: Twenty-five patients (seven female, 60.2 AE 15.1 years) were evaluated. Thickness decrease of retinal nerve fibre layer (RNFL) was associated with a gain in VA over 12 months (r > 0.54; p < 0.05). Decrease in ganglion cell layer (GCL) and GCL+IPL thickness pooled for nasal Early Treatment of Diabetic Retinopathy Study (ETDRS) subfields correlated with VA as follows: ranibizumab r = 0.74 (GCL) and r = 0.63 (GCL+IPL); and triamcinolone r = 0.45 (GCL) and r = 0.46 (GCL+IPL). Conclusion: In DME therapy, reduction in RNFL thickness may have a considerable impact on retinal function, unrelated to the type of pharmacological treatment. Precise morphologic quantification of neurosensory layers by SD OCT offers new insight into disease pathology and therapeutic targets.
Introduction
Within the past decade, optical coherence tomography (OCT) has been rapidly integrated into the diagnosis and therapeutic management of exudative macular diseases such as DME. Morphologic details of DME such as intraretinal cystoid changes, hard exudates or the integrity of the intraretinal and photoreceptor layers can be characterized in a complex and thorough evaluation of each OCT scan (Kim et al. 2006; De ak et al. 2010; Shin et al. 2012; Sun et al. 2016) . The inability to easily quantify specific pathomorphologic changes is a limitation to applying big data analyses. Hence, central retinal thickness (CRT) measured automatically is still the main diagnostic value for monitoring treatment success in multicentre studies, despite the poor correlate of CRT and function in DME (Nunes et al. 2010) .
Recent improvements in OCT not only increased image resolution but also offer a customized technology for individual retinal layer segmentation. Automated parapapillary RNFL segmentation has become common for glaucoma diagnosis in clinical practice. Additional information about glaucoma and various neurodegenerative diseases could be gained by assessing ganglion cell-inner plexiform layer (GCIPL) thickness in the macular region (Loss et al. 2013; Bussel et al. 2014; Garcia-martin et al. 2014; Jeoung et al. 2016) . As signs of neurodegeneration are also prevalent in patients with diabetes, the impact of intravitreal medication on morphological and functional changes needs to be investigated in detail.
Two agents that are commonly applied intravitreally have repeatedly been proven to be effective for treating DME (Massin et al. 2010; Nguyen et al. 2010; Mitchell et al. 2011; The Diabetic Retinopathy Clinical Research Network 2015) . Although both agent types lead to overall oedema reduction and a gain in VA, the cumulative effects of repeated intravitreal injections into the neuroretina in long-term vascular endothelial growth factor (VEGF) suppression remain an issue. In this study, patients treated PRN with either ranibizumab or triamcinolone were followed carefully each month for the study period of a year. A customized semi-automated segmentation algorithm was used for thickness measurements of seven individual retinal layers, averaged for each subfield of the ETDRS macular map (Fig. 1) . To capture signs of neurodegeneration affecting VA, the thickness of the RNFL, GCL and inner plexiform layer (IPL) in the inner and outer nasal subfields as well as the two (= inner and outer) upper and two lower ETDRS subfields was pooled for analyses. Additionally, thickness changes over the course of treatment were monitored and correlated with changes in VA to explore the effect of treatment on each individual retinal layer.
Materials and Methods

Study design and participants
Post hoc OCT data analysis of a prospective single-centre randomized, double-masked clinical trial that adhered to the Declarations of Helsinki was registered at clinicaltrials.gov (NCT00682539) and approved by the responsible ethics committee of the Medical University Vienna (EK363/ 2007) as well as by the Austrian Agency for Health and Food safety (AGES). Details of the study protocol have been published elsewhere (Kriechbaum et al. 2014) . In short, patients with diabetes and a centre involving DME CRT > 300 lm measured with SD-OCT (Spectralis, Heidelberg Engineering GmbH, Dossenheim, Germany)) were randomized to receive either ranibizumab (0.5 mg) or intravitreal triamcinolone (8 mg). After a loading dose of three ranibizumab injections or a single intravitreal triamcinolone injection, patients were reassessed monthly for PRN treatment based on CRT and best-corrected visual acuity (BCVA).
Data collection and data assessment
Central retinal thickness values were verified by reviewing the OCT scans for segmentation errors at the inner limiting membrane (ILM) and retinal pigment epithelium (RPE) and correcting them manually if necessary. Each of the seven retinal layers graded in this study was delineated by an automated segmentation algorithm in SD-OCT. Subsequently, an investigator (JH) masked to the patients' treatment assignment manually adjusted the segmentation in each of the 49 scans of the macular cube at baseline and at the end of the study at month 12 using the HRA/ Spectralis viewing module version 6.0.9 (Fig. 1A) . The mean thickness of each retinal layer was then calculated for each of the nine individual ETDRS subfields by Spectralis segmentation software. In addition, the mean retinal layer thickness values of the central, four inner and four outer ETDRS subfields were calculated. The mean layer thicknesses of the inner and outer nasal ETDRS subfields covering the area of the papillomacular bundle were pooled for analyses to detect changes associated with visual function. Areas of similar nerve fibre density were also pooled: the inner superior and the inner inferior as well as the outer superior and the outer inferior ETDRS subfields (Fig. 1B) .
Statistics
Baseline characteristics of patients were compared across treatment groups by Fisher's exact probability test for dichotomous, Fisher-Freeman-Halton test for categorical and Mann-Whitney test for metric variables. Comparisons of treatment groups with respect to ETDRS subfields at baseline and at month 12 were made by multivariate analysis of variance separately for inner and outer subfields. Correlation between BCVA and CRT as well as individual layer thickness at baseline was investigated by computing Spearman correlation coefficients. The relation between change in BCVA and change in retinal layer thickness was analysed by linear regression. A corrected p-value of <0.05 was considered significant.
Results
Baseline characteristics were similar in both treatment arms (Table 1 ). The mean age was 60.2 AE 15.1 years and mean diabetes duration 14.2 AE 9.5 years. About half of the patients were treatment na€ ıve with ten eyes having received prior laser and seven eyes prior intravitreal therapy for DME. The overall treatment response reflected in BCVA and CRT at each quartile is summarized in Table 2 .
Effect on individual retinal layers
In the whole study group, each retinal layer except the RNFL was significantly thicker (p < 0.05) in the four inner than in the four outer ETDRS fields at baseline and month 12 (Fig. 2 , Table 3 ).
The treatment effect in oedema reduction was reflected in the thinning of each individual retinal layer, which was similar in both treatment arms. Compared with baseline, the greatest shedding in individual layer thickness was found in the outer nuclear layer (ONL) in both treatment arms (ranibizumab: À46 AE 61 lm, p = 0.041; triamcinolone: À29 AE 55lm, p = 0.063).
Correlation of BCVA with individual layer thickness in the central subfield At baseline, there was a trend for CRT and BCVA to correlate (r = 0.57). Individual correlation of each retinal layer thickness with BCVA revealed the following in both treatment arms: the thickness of the RNFL, GCL and IPL in the central subfield correlated significantly (p < 0.05) with BCVA (r = 0.46, p = 0.021; r = 0.51, p = 0.009; and r = 0.45, p = 0.024), but the inner nuclear layer (INL, r = 0.26), the outer plexiform layer (OPL, r = 0.33), the outer nuclear layer (ONL, r = 0.33) and the photoreceptor layer (PR, r = 0.02) did not correlate significantly. Twelve months after the initial study injection, only the decrease in RNFL and GCL + INL thickness in the four inner ETDRS subfields was associated with an increase in VA in the ranibizumab group (r = 0.61 and r = 0.57, respectively). In the triamcinolone group, statistically significant correlations between gain in BCVA letter score and decrease in retinal layer thickness were found in the RNFL (r = 0.57), OPL (r = 0.69) and ONL (r = 0.67).
Correlation of morphology with function in regard to ETDRS subfields
Changes in mean RNFL thickness in all ETDRS subfields from baseline to month 12 correlated moderately to well (r ranges between 0.41 and 0.76) with the BCVA gain in both treatment arms (Fig. 1B) . Decreases in mean GCL and At baseline, thickening was present in all retinal layers but most pronounced in the ONL. ILM = inner limiting membrane; RNFL = retinal nerve fibre layer; GCL = ganglion cell layer; IPL = inner plexiform layer; INL = inner nuclear layer; OPL = outer plexiform layer; ONL = outer nuclear layer; PR = photoreceptor layer, which was measured between basement membrane and external limiting membrane.
GCL+IPL thickness in both nasal segments (inner nasal and outer nasal ETDRS subfields) were significantly correlated with VA gain in the ranibizumab group (r = 0.74 and r = 0.63, respectively), but not in the triamcinolone group (r = 0.45). The mean GCL thickness change in both superior and inferior subfields compared with baseline did not correlate significantly with BCVA change in either of the treatment arms. Analysing the mean thickness values of the four inner and four outer ETDRS subfields (inner and outer ring) at baseline and at month 12, there was no significant correlation of any retinal layer with absolute BCVA values. No relevant correlation was found for the mean RNFL thickness either at nasal subfields covering to the papillomacular bundle (inner nasal + outer nasal; r = 0.33) or at the inner and outer superior together with the inner and outer inferior ETDRS subfields (r = 0.37) at baseline.
Discussion
This clinical study evaluated the importance of additional information provided by new data analysis software. To our knowledge, this is the first study to segment and follow each individual retinal layer thickness in a complete stack of 49 macular OCT scans in patients repeatedly receiving either ranibizumab or triamcinolone for DME therapy over 12 months. Our data on overall treatment response reflected in changes in CRT and BCVA accord with previous studies, which have proven the clinical efficacy of ranibizumab and triamcinolone for treating DME (Massin et al. 2010; Mitchell et al. 2011; The Diabetic Retinopathy Clinical Research Network 2015) . Seven retinal layers were segmented in an OCT stack that covered the macula to find additional quantifiable biomarkers.
So far, subtle changes in retinal layer thickness have been described in early retinopathy (Chhablani et al. 2015; Sk et al. n.d.) . Although various OCT segmentation algorithms have been introduced recently, a device-specific normative reference database of retinal layer thickness values still needs to be established (Ctori & Huntjens 2015) . As such a cohort was not part of our initial study protocol, we compared our results to data previously published by our group: 30 patients with diabetes but without DME (mean age: 44.9 AE 10.6a; mean diabetes duration: 28.7 AE 8.8a) were evaluated using the same software (Pemp et al. 2015) . In our study, each retinal layer in patients with DME was thicker than that in the patients who had diabetes but no DME (Table 4) : The RNFL, OPL and ONL were thickened statistically significantly in the four outer ETDRS subfields, and the INL and ONL were thickened in the four inner ETDRS subfields.
Previous studies focusing on peripapillary OCT scans have demonstrated a swelling of the RNFL in DME (Hwang et al. 2014 ). This finding agrees well with our data, showing a statistically significant RNFL thickening also in the RNFL = retinal nerve fibre layer; GCL = ganglion cell layer; IPL = inner plexiform layer; INL = inner nuclear layer; OPL = outer plexiform layer; ONL = outer nuclear layer; PR = photoreceptor layer. RNFL = retinal nerve fibre layer; GCL = ganglion cell layer; IPL = inner plexiform layer; INL = inner nuclear layer; OPL = outer plexiform layer; ONL = outer nuclear layer; ranib = ranibizumab; triam = triamcinolone; INNER = thickness values of four inner ETDRS subfields pooled; OUTER = thickness values of four outer ETDRS subfields pooled. The first two columns compare the individual retinal layer thicknesses between the treatment arms at two time-points (baseline and month 12). Layer thickness was similar in the two treatment arms at baseline and after 12 months of PRN treatment. Third column 'DME/no oedema' compares thickness values of a reference cohort of 30 patients with type 1 diabetes without DME (Pemp et al. 2015) to layer thickness values of all our study patients at baseline. Significant values are printed in bold letters (significance level <0.05). macular region. Although RNFL and GCL swelling occurred in all ETDRS subfields in patients with DME, oedema reduction in the two nasal ETDRS subfields corresponding to the area of the papillomacular bundle was best correlated with BCVA gain after treatment. This appears plausible because most axons responsible for central VA run within the papillomacular bundle. Similar topical correlations were found in eyes affected by non-arteritic anterior ischaemic optic neuropathy or glaucoma (Kobayashi et al. 2015; Rebolleda et al. 2015) . Thinning of the inner retina at the macula area has been described in patients with diabetes as a sign of early neurodegeneration, even before the first clinical signs of diabetic retinopathy (DR) occur (van Dijk et al. 2012; Chhablani et al. 2015) . In a retrospective analysis, a statistically significant correlation was found between reduced absolute GCL+IPL thickness values and impaired VA after intravitreal anti-VEGF or dexamethasone treatment for DME, which disagrees with our study (Bonnin et al. 2015) . This discrepancy could be due to the macular laser treatment received by almost half of the patients in that study prior to study inclusion whereas only a few patients in our study had received such prior laser treatment. Laser treatment might be crucial for GCL and IPL thickness decrease and BCVA loss due to its destructive nature.
Conceivably, patients with DME in the earlier study had greater thickness values for each individual retinal layer at baseline than our patients had at month 12. Interestingly, there was no association between absolute values of retinal layer thickness and BCVA, but when focusing on the changes after treatment, reduction in RNFL thickness was highly associated with gains in visual function in both treatment arms (Fig. 1B) . It may be hypothesized that the resulting impairment of function is a consequence of impeded axoplasmic transport as an indication of cell damage (Kupersmith et al. 2012; Sim o & Hern andez 2012) . Moreover, neither swelling nor reduction in thickness values of the layers most affected by DME (ONL, OPL, INL) could be associated with a change in BCVA. According to our data, swelling of the inner retinal layers (RNFL, GCL and IPL) had a greater clinical impact on BCVA than thickness changes in the outer retinal layers. These results are consistent with data published previously (Ebneter et al. 2016) .
In our study, seven retinal layers visible in an OCT stack of 49 scans covering a macula area of 6 9 6 mm were automatically segmented by HRA/Spectralis software and subsequently manually corrected if necessary. Even though retinal layer segmentation works adequately in healthy retinas, segmentation errors are frequent in DME. Manual correction is time-consuming and prone to subjective errors. In addition, the previously described disorganization of retinal inner layers in patients with DME poses a further challenge for both automated segmentation and manual correction (Sun et al. 2015) . Therefore, segmentation algorithms still need to be substantially improved before they can be reliably applied in exudative maculopathies.
The major drawback of this study was the relatively small number of study patients. Nevertheless, data were collected in a prospective, doublemasked study following a strict protocol. Seven intraretinal layers in each of the 49 OCT scans covering the macula were thoroughly evaluated by an investigator masked to patients' treatment assignment, and segmentation errors were corrected manually when necessary. As we had no control group without DME in our primary study design, we used a full data set of retinal layer thickness measurements from patients with diabetes but without DME evaluated with the same segmentation software in a study presented previously by our study group.
To our knowledge, this is the first study to segment seven individual retinal layers in the entire area of the macula in patients with DME to quantify their layer thickness and monitor their treatment response pursuing two different treatment strategies. Oedema reduction of the inner retinal layers was shown to be associated with VA gain in patients with DME receiving treatment. The strongest correlation of thickness change with BCVA gain was observed at the papillomacular bundle. However, future studies with larger, more stratified cohorts will be needed to further investigate and confirm the impact of RNFL, GCL and IPL thickness changes on neuroretinal function.
In conclusion, segmentation of inner retinal layers seems to be of greater clinical importance for retinal function in patients with DME than evaluation of thickness values of the outer retina.
